Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2011 1
2012 1
2013 1
2014 1
2015 1
2016 2
2018 2
2020 1
2021 5
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial.
Rosenstock J, Emral R, Sauque-Reyna L, Mohan V, Trescolí C, Al Sifri S, Lalic N, Alvarez A, Picard P, Bonnemaire M, Demil N, McCrimmon RJ; SoliMix Trial Investigators. Rosenstock J, et al. Among authors: al sifri s. Diabetes Care. 2021 Jun 28;44(10):2361-70. doi: 10.2337/dc21-0393. Online ahead of print. Diabetes Care. 2021. PMID: 34183429 Free PMC article.
Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit.
Al Saleh Y, Al Busaidi N, Al Dahi W, Almajnoni M, Mohammed AS, Alshali K, Al-Shamiri M, Al Sifri S, Arafah M, Chan SP, El-Tamimi H, Hafidh K, Hassanein M, Shaaban A, Sultan A, Grassi G. Al Saleh Y, et al. Among authors: al sifri s. Adv Ther. 2023 Jul;40(7):2965-2984. doi: 10.1007/s12325-023-02529-7. Epub 2023 May 26. Adv Ther. 2023. PMID: 37233878 Free PMC article. Review.
The Transcultural Diabetes Nutrition Algorithm: A Middle Eastern Version.
Hamdy O, Al Sifri S, Hassanein M, Al Dawish M, Al-Dahash RA, Alawadi F, Jarrah N, Ballout H, Hegazi R, Amin A, Mechanick JI. Hamdy O, et al. Among authors: al sifri s. Front Nutr. 2022 Jun 13;9:899393. doi: 10.3389/fnut.2022.899393. eCollection 2022. Front Nutr. 2022. PMID: 35769383 Free PMC article. Review.
Dyslipidaemia in the Middle East: Current status and a call for action.
Al Rasadi K, Almahmeed W, AlHabib KF, Abifadel M, Farhan HA, AlSifri S, Jambart S, Zubaid M, Awan Z, Al-Waili K, Barter P. Al Rasadi K, et al. Atherosclerosis. 2016 Sep;252:182-187. doi: 10.1016/j.atherosclerosis.2016.07.925. Epub 2016 Jul 30. Atherosclerosis. 2016. PMID: 27522462 Free article. Review.
Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study.
Hassanein M, Malek R, Shaltout I, Sahay RK, Buyukbese MA, Djaballah K, Pilorget V, Coudert M, Al Sifri S; SoliRam Study Investigators. Hassanein M, et al. Among authors: al sifri s. Diabetes Metab Syndr. 2023 Feb;17(2):102707. doi: 10.1016/j.dsx.2023.102707. Epub 2023 Jan 11. Diabetes Metab Syndr. 2023. PMID: 36680967 Free article.
Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study.
Malik RA, Elhadd T, Alattar A, Al Shaikh A, Al Randi M, Arora R, Al-Sifri S, Akil Y, Magdy A, Naqvi M, Hassanein M. Malik RA, et al. Among authors: al sifri s. Diabetes Ther. 2022 Mar;13(3):569-581. doi: 10.1007/s13300-022-01225-z. Epub 2022 Mar 3. Diabetes Ther. 2022. PMID: 35239165 Free PMC article.
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.
McCrimmon RJ, Al Sifri S, Emral R, Mohan V, Sauque-Reyna L, Trescolí C, Lalic N, Alvarez A, Demil N, Coudert M, Shaunik A, Bonnemaire M, Rosenstock J; SoliMix Trial investigators. McCrimmon RJ, et al. Among authors: al sifri s. Diabetes Obes Metab. 2021 Jun;23(6):1221-1231. doi: 10.1111/dom.14354. Epub 2021 Apr 29. Diabetes Obes Metab. 2021. PMID: 33606908 Clinical Trial.
24 results